Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Intangibles (2016 - 2025)

Cross Country Healthcare's Intangibles history spans 16 years, with the latest figure at $27.6 million for Q4 2025.

  • For Q4 2025, Intangibles fell 34.49% year-over-year to $27.6 million; the TTM value through Dec 2025 reached $27.6 million, down 34.49%, while the annual FY2025 figure was $27.6 million, 34.49% down from the prior year.
  • Intangibles reached $27.6 million in Q4 2025 per CCRN's latest filing, down from $35.5 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $63.1 million in Q1 2023 to a low of $2.9 million in Q2 2022.
  • Average Intangibles over 5 years is $39.8 million, with a median of $41.5 million recorded in 2022.
  • Peak YoY movement for Intangibles: plummeted 60.91% in 2021, then soared 1974.86% in 2023.
  • A 5-year view of Intangibles shows it stood at $48.2 million in 2021, then dropped by 7.3% to $44.7 million in 2022, then grew by 21.79% to $54.5 million in 2023, then decreased by 22.55% to $42.2 million in 2024, then crashed by 34.49% to $27.6 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Intangibles are $27.6 million (Q4 2025), $35.5 million (Q3 2025), and $37.7 million (Q2 2025).